Harvard researchers have pioneered a groundbreaking method for generating large numbers of adult skeletal-muscle satellite cells, also known as muscle stem cells, in vitro.

Powerful combination of 3D bioprinting and stem cell-based tissue engineering could enable new approaches to treating chronic kidney disease

TFome technology, advanced through Blavatnik Biomedical Accelerator, may contribute to new cell therapies

Harvard stem cell research, currently in mice, receives support from Sarepta to advance in-vivo genome editing toward prospective therapy